Pathogenesis of two axonopathies does not require axonal neurofilaments

Area of Science:

• Neuroscience
• Cell Biology
• Pathology

Background:

• Neurofilaments form the axonal cytoskeleton and are implicated in neurodegenerative diseases.
• Abnormal neurofilament accumulation is a hallmark of neuronal damage in conditions like ALS.
• A prevailing hypothesis suggests disrupted neurofilaments are a common toxic intermediate in pathogenesis.

Purpose of the Study:

• To investigate the necessity of axonal neurofilaments in the pathogenesis of neurodegenerative diseases.
• To challenge the model that disrupted neurofilaments are a common toxic intermediate.
• To redefine the components of pathogenic pathways leading to axon disruption.

Main Methods:

• Utilized transgenic mouse models for dystonia musculorum (dt) and SOD1-mediated amyotrophic lateral sclerosis (ALS).
• Generated a transgenic background that prevents neurofilaments from accumulating in the axonal compartment.
• Observed disease progression in these modified mouse models.

Main Results:

• Neurodegenerative disease models (dt and SOD1-ALS) progressed with minimal or no reduction in severity.
• Disease progression occurred on a background where axonal neurofilaments were significantly reduced or absent.
• These findings directly contrast with the hypothesis implicating disrupted neurofilaments as a common toxic intermediate.

Conclusions:

• Axonal neurofilaments are not necessary for the progression of the studied neurodegenerative diseases.
• The role of neurofilaments in the pathogenesis of axon disruption needs re-evaluation.
• These findings redefine key components of the pathogenic pathway in motor neuron diseases.